Burning Rock Biotech (BNR) Interest Expenses (2019 - 2026)

Burning Rock Biotech (BNR) posted quarterly Interest Expenses of -$2000.0 for Q1 2026, little changed on a QoQ basis from -$2000.0 in Q4 2025.

Burning Rock Biotech (BNR) Interest Expenses (2019 - 2026) Analysis & Trends

Burning Rock Biotech (BNR) has reported Interest Expenses for 5 consecutive years, with -$2000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Interest Expenses changed N/A year-over-year to -$2000.0; the TTM figure through Mar 2026 stood at -$6000.0 (changed N/A YoY), while the FY2025 annual figure was -$4000.0, changed N/A from the prior year.
Interest Expenses came in at -$2000.0 for Q1 2026 at Burning Rock Biotech, roughly flat from -$2000.0 in the prior quarter.
The five-year high for Interest Expenses was -$2000.0 in Q3 2025, with the low at -$2000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	48.00 Mn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	354.00 Mn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	63.00 Mn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	7.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	892,000.00
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	25.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	192.00 Mn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	24.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	17.01 Mn
10	Burning Rock Biotech	748.66 Mn	683.48 Mn	11.31 Mn	-2,000.00

Download Data